100712-9Brexpiprazole [Mass/volume] in Serum or PlasmaActive
Part Description
LP429469-2 Brexpiprazole
Brexpiprazole is known as 'atypical' antipsychotic drug approved by the FDA in July 2015 for treatment of schizophrenia and adjunctive therapy for major depressive disorder. [PMID:PMC6007711]
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Brexpiprazole
- Property
- MCnc
- Time
- Pt
- System
- Ser/Plas
- Scale
- Qn
- Method
Additional Names
- Short Name
- Brexpiprazole SerPl-mCnc
- Display Name
- Brexpiprazole [Mass/Vol]
- Consumer Name Alpha
- Brexpiprazole, Blood
Basic Attributes
- Class
- DRUG/TOX
- Type
- Laboratory
- First Released
- Version 2.73
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
Language Variants Get Info
- zh-CNChinese (China)
- 依匹哌唑:
质量浓度: 时间点: 血清/血浆: 定量型: - nl-NLDutch (Netherlands)
- brexpiprazol:
massa/volume: moment: serum of plasma: kwantitatief: - it-ITItalian (Italy)
- Brexpiprazolo:
MCnc: Pt: Siero/Plasma: Qn: - es-ESSpanish (Spain)
- Brexpiprazol:
Concentración de masa: Punto temporal: Suero o Plasma: Qn:
Example Units
| Unit | Source |
|---|---|
| ug/mL | Example UCUM Units |
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=100712-9
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright